HER2-expressing Advanced Solid Tumors
1 clinical trials · Condition
◉ Watch HER2-expressing Advanced Solid Tumors
| Record | Firm | Date |
|---|---|---|
| A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors. (NCT06015048) | Jiangsu HengRui Medicine Co., Ltd. | 2023-08-11 |
Track HER2-expressing Advanced Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.